Yang, Guoqiang
Zhong, Luyi
Wang, Jiayue
Yang, Chenyu
Cyganek, Lukas
Hamdani, Nazha
Zhou, Xiaobo
Fan, Xuehui
El-Battrawy, Ibrahim
Akin, Ibrahim
Funding for this research was provided by:
Health Commission of Sichuan Province Medical Science and Technology Program (24QNMP012)
Brain Disease Innovation Team of the Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University (2022-CXTD-05)
the Integrated Traditional Chinese and Western Medicine Special Project of Southwest Medical University (2024ZXYZX14)
National Natural Science Foundation of China (82200361)
Sichuan Science and Technology Program (2025NSFSC2140)
the BMBF (German Ministry of Education and Research) and DZHK (81Z0500204)
the Hector Foundation (M2401)
Deutsche Forschungs-gemeinschaft (422681845)
Article History
Received: 5 June 2025
Accepted: 5 January 2026
First Online: 6 February 2026
Declarations
:
: The study received approval from both the Ethics Committee of the Medical Faculty Mannheim, Heidelberg University (Title of the approved project: Investigation of the pathophysiology of arrhythmias using cardiomyocytes derived from human induced pluripotent stem cells (hiPSC) in various cardiovascular diseases, Approval number: 2018–565 N-MA, Date of approval: 19/06/2018) and the Ethics Committee of the University Medical Center Göttingen (Title of the approved project: Reprogramming somatic cells into induced pluripotent stem cells to establish a human biobank as a resource for the study of human diseases, Approval No. 10/9/15, Date of approval: February 2, 2016.). The patients or their guardians/next of kin provided written informed consent for participation in the study and/or the use of samples. The study was carried out in accordance with the approved guidelines and in accordance with the Helsinki Declaration of 1975 ( , accessed on 30 May 2022), revised in 2013.
: Not applicable.
: The authors declare no competing interests.